346 related articles for article (PubMed ID: 29620717)
1. The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
Missailidis C; Neogi U; Stenvinkel P; Trøseid M; Nowak P; Bergman P
AIDS; 2018 Jul; 32(12):1589-1598. PubMed ID: 29620717
[TBL] [Abstract][Full Text] [Related]
2. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
[TBL] [Abstract][Full Text] [Related]
3. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
Dillon SM; Kibbie J; Lee EJ; Guo K; Santiago ML; Austin GL; Gianella S; Landay AL; Donovan AM; Frank DN; McCARTER MD; Wilson CC
AIDS; 2017 Feb; 31(4):511-521. PubMed ID: 28002063
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia.
Wang J; Gu X; Yang J; Wei Y; Zhao Y
Front Cell Infect Microbiol; 2019; 9():409. PubMed ID: 31850241
[No Abstract] [Full Text] [Related]
6. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
7. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats.
Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M
Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499
[TBL] [Abstract][Full Text] [Related]
8. Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection.
Haissman JM; Knudsen A; Hoel H; Kjær A; Kristoffersen US; Berge RK; Katzenstein TL; Svardal A; Ueland T; Aukrust P; Lebech AM; Nielsen SD; Trøseid M
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):130-6. PubMed ID: 26413854
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.
Arnbjerg CJ; Vestad B; Hov JR; Pedersen KK; Jespersen S; Johannesen HH; Holm K; Halvorsen B; Fallentin E; Hansen AE; Lange T; Kjær A; Trøseid M; Fischer BM; Nielsen SD
J Acquir Immune Defic Syndr; 2018 Aug; 78(4):450-457. PubMed ID: 29874201
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
12. Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
Srinivasa S; Fitch KV; Lo J; Kadar H; Knight R; Wong K; Abbara S; Gauguier D; Capeau J; Boccara F; Grinspoon SK
AIDS; 2015 Feb; 29(4):443-52. PubMed ID: 25565500
[TBL] [Abstract][Full Text] [Related]
13. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
[TBL] [Abstract][Full Text] [Related]
14. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
[TBL] [Abstract][Full Text] [Related]
15. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
[TBL] [Abstract][Full Text] [Related]
16. Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (
Dalla Via A; Gargari G; Taverniti V; Rondini G; Velardi I; Gambaro V; Visconti GL; De Vitis V; Gardana C; Ragg E; Pinto A; Riso P; Guglielmetti S
Nutrients; 2019 Dec; 12(1):. PubMed ID: 31881690
[TBL] [Abstract][Full Text] [Related]
17. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
Sessa L; Reddel S; Manno E; Quagliariello A; Cotugno N; Del Chierico F; Amodio D; Capponi C; Leone F; Bernardi S; Rossi P; Putignani L; Palma P
AIDS; 2019 May; 33(6):1001-1011. PubMed ID: 30946154
[TBL] [Abstract][Full Text] [Related]
18. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
19. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota.
Deusch S; Serrano-Villar S; Rojo D; Martínez-Martínez M; Bargiela R; Vázquez-Castellanos JF; Sainz T; Barbas C; Moya A; Moreno S; Gosalbes MJ; Estrada V; Seifert J; Ferrer M
AIDS; 2018 Jun; 32(10):1229-1237. PubMed ID: 29683848
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the gut microbiota associated with HIV-1 infection.
Lozupone CA; Li M; Campbell TB; Flores SC; Linderman D; Gebert MJ; Knight R; Fontenot AP; Palmer BE
Cell Host Microbe; 2013 Sep; 14(3):329-39. PubMed ID: 24034618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]